I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A phase I, open label, clinical study to assess the safety ..:
Hitt Sharma
;
Sanjay Lalwani
;
Sameer Parekh
...
http://dx.doi.org/10.1080/21645515.2022.2146435. , 2022
Link:
https://doi.org/10.1080/21645515.2022.2146435
RT Journal T1
A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:cdd376e1788d4b8c9561126652699c3f&Exemplar=1&LAN=DE A1 Hitt Sharma A1 Sanjay Lalwani A1 Sameer Parekh A1 Pramod Pujari A1 Sunil Shewale A1 Sonali Palkar A1 Neeta Hanumante A1 Shilpa Gokhale A1 Jaganathan Ks A1 Rakesh Kumar A1 Inderjit Sharma A1 Sunil Gairola PB Taylor & Francis Group YR 2022 K1 hexavalent K1 toddler K1 phase i K1 vaccine K1 safety K1 Immunologic diseases. Allergy K1 RC581-607 K1 Therapeutics. Pharmacology K1 RM1-950 JF http://dx.doi.org/10.1080/21645515.2022.2146435 LK http://dx.doi.org/https://doi.org/10.1080/21645515.2022.2146435 DO https://doi.org/10.1080/21645515.2022.2146435 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)